Fund Holdings — Saturn V Capital Management LP

Total Portfolio Value:
$697.47M
Total Bought:
$153.34M
Total Sold:
$76.63M
Net Transaction:
+$76.71M
Notable People:
Xiaoying (Nmn) Tian, Douglas Kevin Edwards
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Amylyx Pharmaceuticals, Inc.(AMLX)4,349,8854,624,101+274,216$60.46M$83.05M11.91%+$22.59M
ALUMIS INC3,202,0752,915,443-286,632$70.54M$82.04M11.76%+$11.50M
ABIVAX Société Anonyme(ABVX)542,696518,865-23,831$60.43M$69.14M9.91%+$8.71M
Vaxcyte, Inc.(PCVX)824,532852,914+28,382$47.91M$49.58M7.11%+$1.67M
IMMIX BIOPHARMA INC3,693,5854,658,429+964,844$33.65M$48.03M6.89%+$14.38M
PHARVARIS N V
COM
1,201,4021,314,122+112,720$33.94M$45.44M6.52%+$11.50M
Jazz Pharmaceuticals plc(JAZZ)162,961160,938-2,023$30.81M$38.78M5.56%+$7.97M
Celcuity Inc.(CELC)281,904370,318+88,414$32.18M$38.74M5.55%+$6.57M
Disc Medicine, Inc.(IRON)449,926524,730+74,804$28.77M$38.38M5.50%+$9.61M
CANDEL THERAPEUTICS INC2,896,5883,303,686+407,098$14.19M$34.03M4.88%+$19.83M
X4 PHARMACEUTICALS INC6,456,6466,973,343+516,697$26.67M$32.57M4.67%+$5.90M
MONOPAR THERAPEUTICS INC345,626311,976-33,650$18.94M$28.89M4.14%+$9.95M
Dyne Therapeutics, Inc.(DYN)966,6091,057,493+90,884$17.52M$23.49M3.37%+$5.96M
Trevi Therapeutics, Inc.(TRVI)01,052,043+1,052,043$0$19.62M2.81%+$19.62M
ZURA BIO LTD739,9602,101,119+1,361,159$4.40M$12.40M1.78%+$7.99M
SAGIMET BIOSCIENCES INC01,479,918+1,479,918$0$11.44M1.64%+$11.44M
OCULIS HOLDING AG516,761684,880+168,119$13.74M$9.50M1.36%-$4.24M
INHIBIKASE THERAPEUTICS INC3,863,4453,869,056+5,611$6.49M$7.85M1.13%+$1.36M
Vir Biotechnology, Inc.(VIR)0770,643+770,643$0$7.85M1.13%+$7.85M
INVIVYD INC10,949,0848,392,288-2,556,796$14.23M$7.32M1.05%-$6.91M
Alto Neuroscience, Inc.(ANRO)88,999182,829+93,830$2.00M$4.82M0.69%+$2.82M
SATELLOS BIOSCIENCE INC350,000350,0000$1.97M$2.72M0.39%+$750.8K
OVID THERAPEUTICS INC4,166,666663,060-3,503,606$9.25M$1.78M0.26%-$7.47M
Cogent Biosciences, Inc.(COGT)626,6350-626,635$24.12M$0—-$24.12M
Page 1 of 1